CEIDR brings together a range of highly specialised facilities that accommodate the full lifecycle of discovery, development and deployment – all contained within less than a square mile of the city. These facilities are adjacent to the newly built £335 million Royal Liverpool University Hospital, which will open in 2017 and contains Merseyside’s Tropical and Infectious Disease Unit.
CEIDR has been boosted by £200 million investment across the three adjoining campuses of:
- The £33 million Liverpool Bio Innovation Hub – a collaborative venture which brings together current biobanks and tissue collections
- The £28 million Centre for Tropical & Infectious Diseases – a leading specialist research centre for microbial diseases
- The £7 million Wolfson Building – designed to support T1 and T2 translation activities in infection
- A £68 million Materials Innovation Factory at the University of Liverpool in partnership with Unilever which will drive the discovery of novel materials, including applications in nanomedicine, drug delivery and ‘omics’ biotechnology
- A £24 million Liverpool Life Sciences Accelerator Building with space for SMEs due to open in 2017 which will provide access to fully staffed Category 3 antimicrobial, parasitology and insectary provision to facilitate rapid biological screening of candidate molecules
- The Ronald Ross Building, a £40 million state-of-the-art facility, which houses the University of Liverpool’s Institute of Infection and Global Health, and has in vivo and in vitro containment level III laboratories.